NCT03778892

Brief Summary

A randomized controlled clinical trial looking at the effect of use of a mobile phone application in addition to standard care compared to standard care alone at a youth-friendly clinic in young men who have sex with men and transgender women aged between 15-19 years at risk of HIV on PrEP adherence.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 19, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2019

Completed
Last Updated

January 23, 2020

Status Verified

January 1, 2020

Enrollment Period

1.8 years

First QC Date

December 8, 2018

Last Update Submit

January 21, 2020

Conditions

Keywords

PrEP adherenceYouthAdolescentsMSMHIV PreventionMobile Health

Outcome Measures

Primary Outcomes (3)

  • PrEP Adherence

    Self-Reported Adherence

    Weekly self-reported adherence for a period of 6 months following randomization

  • PrEP Adherence at 3 months

    Measured Serum TDF-DP Level (from dried blood spots)

    Measured at month 3 (measure of 17 day half life of TDF-DP)

  • PrEP Adherence at 6 months

    Measured Serum TDF-DP Level (from dried blood spots)

    Measured at month 6 (measure of 17 day half life of TDF-DP)

Secondary Outcomes (8)

  • HIV infection rates

    duration of study (6 months)

  • Rates of Urethral Neisseria gonorrhea

    duration of study (6 months)

  • Behaviour Risk-Taking

    duration of study (6 months)

  • Rates of Anal Neisseria gonorrhea

    duration of study (6 months)

  • Rates of Urethral Chlamydia trachomatis

    duration of study (6 months)

  • +3 more secondary outcomes

Study Arms (2)

Novel Intervention

EXPERIMENTAL

Use of a mobile phone application to support PrEP adherence in addition to youth-friendly counselling and services

Behavioral: 'Project Raincoat' Mobile Phone Application

Standard Intervention

NO INTERVENTION

Use of a mobile phone application to support PrEP adherence in addition to youth-friendly counselling and services

Interventions

Mobile phone application with weekly input channels for PrEP use, condom use, number of sex partners and sex acts and a calculation of self-HIV risk feedback scoring. Scoring system for attendance of visits, normal blood tests and use of application. Points redeemable for cash. Optional alarm system to remind to take medications and attend visits.

Novel Intervention

Eligibility Criteria

Age15 Years - 19 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmen who have sex with men or transgender women
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent men who have sex with men
  • At high risk of HIV infection (have at least one of the following)
  • More than 1 sexual partner in the last 6 months
  • Irregular condom use during sexual intercourse
  • HIV positive sexual partner
  • Age 15 to under 20 years old
  • A desire to take PrEP to prevent HIV infection
  • Tested HIV negative within 1 month of enrolment
  • Able to provide written consent or assent to take part in the clinical trial

You may not qualify if:

  • Signs or symptoms of acute retroviral syndrome that cannot be confirmed to be due to alternate causes, including unremitting fevers, headaches, myalgia, fatigue, and lymphadenopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thai Red Cross AIDS Research Center

Bangkok, 10330, Thailand

Location

Related Publications (2)

  • Kawichai S, Songtaweesin WN, Wongharn P, Phanuphak N, Cressey TR, Moonwong J, Vasinonta A, Saisaengjan C, Chinbunchorn T, Puthanakit T. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2022 Apr 21;10(4):e25561. doi: 10.2196/25561.

  • Songtaweesin WN, Kawichai S, Phanuphak N, Cressey TR, Wongharn P, Saisaengjan C, Chinbunchorn T, Janyam S, Linjongrat D, Puthanakit T; CE-PID - TRC Adolescent Study Team. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc. 2020 Sep;23 Suppl 5(Suppl 5):e25564. doi: 10.1002/jia2.25564.

MeSH Terms

Conditions

Medication AdherenceAdolescent Behavior

Condition Hierarchy (Ancestors)

Patient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: half of study participants will receive the intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Clinical Researcher

Study Record Dates

First Submitted

December 8, 2018

First Posted

December 19, 2018

Study Start

March 1, 2018

Primary Completion

December 15, 2019

Study Completion

December 15, 2019

Last Updated

January 23, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations